Cargando…

Hospitalizations in patients with idiopathic pulmonary fibrosis

BACKGROUND: Hospitalizations are common among patients with idiopathic pulmonary fibrosis (IPF). We investigated the impact of hospitalizations on outcomes in patients with IPF. METHODS: The IPF-PRO Registry is an observational US registry that enrolled patients with IPF that was diagnosed or confir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun J., Snyder, Laurie D., Adegunsoye, Ayodeji, Neely, Megan L., Bender, Shaun, White, Eric S., Conoscenti, Craig S., Strek, Mary E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481759/ https://www.ncbi.nlm.nih.gov/pubmed/34592998 http://dx.doi.org/10.1186/s12931-021-01851-4

Ejemplares similares

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
por: Case, Amy Hajari, et al.
Publicado: (2020)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry
por: Salisbury, Margaret L., et al.
Publicado: (2020)

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
por: de Andrade, Joao A., et al.
Publicado: (2022)

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018
por: Durheim, Michael T., et al.
Publicado: (2020)

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
por: Snyder, Laurie, et al.
Publicado: (2019)

Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
por: Kim, Hyun J., et al.
Publicado: (2022)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study
por: Durheim, Michael T., et al.
Publicado: (2019)

Lung function trajectories in patients with idiopathic pulmonary fibrosis
por: Neely, Megan L, et al.
Publicado: (2023)

Skewed Lung CCR4 to CCR6 CD4(+) T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Therapeutic Approach to Adult Fibrotic Lung Diseases
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
por: Chung, Jonathan H., et al.
Publicado: (2021)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
por: Maher, Toby M., et al.
Publicado: (2019)

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry
por: Swaminathan, Aparna C., et al.
Publicado: (2022)

Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
por: Adegunsoye, Ayodeji, et al.
Publicado: (2015)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

The psychometric properties of the St George’s Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review
por: Swigris, Jeffrey J, et al.
Publicado: (2014)

Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
por: O'Brien, Emily C, et al.
Publicado: (2016)

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
por: Oldham, Justin M., et al.
Publicado: (2023)

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
por: Astor, Todd L., et al.
Publicado: (2023)

Computer-Aided Pulmonary Fibrosis Detection Leveraging an Advanced Artificial Intelligence Triage and Notification Software
por: Selvan, Kavitha C., et al.
Publicado: (2023)

Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
por: Ruan, Peifeng, et al.
Publicado: (2023)

Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials
por: Swigris, Jeffrey J, et al.
Publicado: (2018)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
por: Huang, Yong, et al.
Publicado: (2015)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis
por: Guillen-Guio, Beatriz, et al.
Publicado: (2023)

Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States
por: Singer, David, et al.
Publicado: (2022)

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
por: Allen, Richard J., et al.
Publicado: (2020)

Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease
por: Biblowitz, Kathleen, et al.
Publicado: (2021)

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022)

Advances in the management of idiopathic pulmonary fibrosis
por: Ryu, Jay H, et al.
Publicado: (2010)

Organoid Model in Idiopathic Pulmonary Fibrosis
por: Lee, Jooyeon, et al.
Publicado: (2020)

T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival
por: Bonham, Catherine A., et al.
Publicado: (2019)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

A 20-year-old woman with rapidly progressive dyspnea and diffuse pulmonary infiltrates
por: Adegunsoye, Ayodeji O., et al.
Publicado: (2011)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pkote0ooicd6ip4op48se624tf